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Background: Adenosine triphosphate (ATP) is secreted from hepatocytes under physiological conditions and plays
an important role in liver biology through the activation of P2 receptors. Conversely, higher extracellular ATP
concentrations, as observed during necrosis, trigger inflammatory responses that contribute to the progression of
liver injury. Impaired calcium (Ca2+) homeostasis is a hallmark of acetaminophen (APAP)-induced hepatotoxicity,
and since ATP induces mobilization of the intracellular Ca2+ stocks, we evaluated if the release of ATP during
APAP-induced necrosis could directly contribute to hepatocyte death.
Results: APAP overdose resulted in liver necrosis, massive neutrophil infiltration and large non-perfused areas, as
well as remote lung inflammation. In the liver, these effects were significantly abrogated after ATP metabolism by
apyrase or P2X receptors blockage, but none of the treatments prevented remote lung inflammation, suggesting a
confined local contribution of purinergic signaling into liver environment. In vitro, APAP administration to primary
mouse hepatocytes and also HepG2 cells caused cell death in a dose-dependent manner. Interestingly, exposure of
HepG2 cells to APAP elicited significant release of ATP to the supernatant in levels that were high enough to
promote direct cytotoxicity to healthy primary hepatocytes or HepG2 cells. In agreement to our in vivo results,
apyrase treatment or blockage of P2 receptors reduced APAP cytotoxicity. Likewise, ATP exposure caused significant
higher intracellular Ca2+ signal in APAP-treated primary hepatocytes, which was reproduced in HepG2 cells.
Quantitative real time PCR showed that APAP-challenged HepG2 cells expressed higher levels of several purinergic
receptors, which may explain the hypersensitivity to extracellular ATP. This phenotype was confirmed in humans
analyzing liver biopsies from patients diagnosed with acute hepatic failure.
Conclusion: We suggest that under pathological conditions, ATP may act not only an immune system activator,
but also as a paracrine direct cytotoxic DAMP through the dysregulation of Ca2+ homeostasis.
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The abusive use of medications is a major health issue and
accounts every year to huge hospitalization costs and sev-
eral deaths. Analgesics are one of the first alternatives to
treat fever and pain, and acetaminophen is the most
frequent drug found in these formulations. It is not surpris-
ing that the cases of acetaminophen overdose are still
frequent in the clinics, and since the liver is a central organ
in acetaminophen detoxification, hepatocytes are directly
damaged during overdose. Despite the liver ability to regen-
erate after injury, a massive cell death may trigger an in-
flammatory response that accounts to additional injury.
One of the strategies to restrict organ injury is to control
liver inflammation, avoiding organ failure. Here we show
that ATP, a key molecule in cell bioenergetics, is also
involved in liver inflammation. When cells die, they release
ATP to the extracellular environment and this may directly
cause additional cell hepatocyte death. These effects may be
explained by ATP ability to directly cause intracellular ionic
dysregulation in acetaminophen-treated cells. Mice that
received an overdose of acetaminophen had significantly
less liver damage when extracellular ATP actions were
inhibited. Also, human-derived cells cultivated in vitro were
also protected from these toxic effects when the same
blockage strategy was employed. Finally, we established that
liver samples from patients suffering from acute hepatitis
expressed more receptors to ATP, which suggests that a
similar amplifying effect happened during their disease. In
this sense, we provided evidence that managing liver
response to extracellular ATP released from dead cells may
hold future opportunities to avoid liver failure, transplanta-
tions and death.
Background
Drug-induced liver injury (DILI) is an adverse drug reaction
that causes acute hepatocyte death. There are several differ-
ent grades of DILI, which range from an asymptomatic le-
sion (detectable only by serum transaminases analysis) to
severe cases that require liver transplantation [1]. However,
20% to 50% of eligible patients die before a transplant
becomes available as a result of hepatic encephalopathy
and multiple organ failure [2], indicating that novel therap-
ies aimed to control the progression of liver damage are
extremely necessary. The most common cause of DILI is
the overdose of acetaminophen (APAP), a popular antipyr-
etic and analgesic drug. Following APAP administration, its
reactive metabolite NAPQI (N-acetyl-p-benzoquinone
imine) accumulates within hepatocytes, causing cell death
mainly by oncotic necrosis [3].
When cells die under such stressing situations,
their intracellular contents are spilled to the intersti-
tium and trigger inflammation by directly causing
damage to adjacent cells or activating resident cells
to release pro-inflammatory mediators. In the lattercase, these molecules are called damage-associated
molecular patterns (DAMPs) [4]. In general, immune
cells express receptors to almost all molecules that
originally inhabit the intracellular compartment [5,6],
but not all DAMPs are exclusively associated with
immune responses. For example, cells can secrete
ATP to modulate intracellular functions, including
cytosolic calcium (Ca2+) concentration and energetic
balance [7-9]. However, extracellular ATP concentra-
tion significantly increases during necrosis, which in
turn activates inflammasome assembling via P2X7
receptor, leading to release of IL-1β [5,10]. The in-
flammatory response triggered by necrosis-derived
ATP was recently described as an important factor
to liver injury progression, and activation of P2X7
receptor is required for manifestations of APAP-
induced injury [11].
Impaired intracellular Ca2+ management is also
observed during APAP-induced hepatotoxicity, and it is
closely related to the onset of cell death [12]. Moreover,
intracellular Ca2+ accumulation, particularly into the nu-
cleus, causes DNA fragmentation by endonucleases,
accelerating the progression of APAP-dependent cellular
necrosis [13], indicating that molecules with ability to
increase Ca2+ signaling may cause catastrophic conse-
quences to APAP-challenged cells. ATP induces Ca2+
mobilization from intracellular stocks [14] and also by
opening Ca2+ permeable channels in the membrane via
P2 receptors [15]. Taking into account the increased
extracellular ATP concentration found during necrosis,
we hypothesized that excessive interstitial ATP might
contribute to liver injury progression not only via im-
mune system stimulation, but also by worsening
intracellular Ca2+ imbalance observed during APAP
administration, acting as a direct cytotoxic DAMP.
Results
Acetaminophen-induced liver damage, but not remote
lung inflammation, is dependent on extracellular ATP
signaling
Previous data from our group showed that ATP is
released following liver necrosis [16]. Initially, the
participation of extracellular ATP in APAP-induced liver
injury was investigated by liver confocal intravital
microscopy as previously described [16,17]. Control
mice presented a fully perfused liver microvasculature,
as shown by the regular staining of sinusoids by
phycoeritrin (PE)-coupled anti-CD31 (Figure 1A; red
channel; Control), and a few neutrophils were found
within sinusoids (green channel; Additional file 1: Video
1). However, marked liver necrosis and increased neu-
trophil infiltration (an indicative of liver inflammation)
were observed following 24 hours of APAP administra-
tion (500 mg/Kg), revealing also large non-perfused areas
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Additional file 2: Video 2). Histopathology analysis
(H&E stained slides) confirmed liver necrosis induced by
APAP treatment (Figure 1B; control in comparison to
APAP; arrow heads), which was diminished following
extracellular ATP metabolism by exogenous ATPase
(Figure 1B; Apy; apyrase grade VII; 25 U/mice; 24 h). In
addition, apyrase significantly reduced liver injury
(assessed by serum levels of ALT; Figure 1C) and neu-
trophil infiltration (Figure 1A; Apy; Additional file 3:
Video 3). After APAP administration, increased serum
levels of pro-inflammatory cytokines (including TNF-α
and IL-1β) were observed, which were significantly
reduced by apyrase treatment (Figure 1D-E). Likewise,
blockage of P2X (TNP-ATP; 1 mg/Kg; 24 h) or P2X7
(oxi-ATP; 9 mg/Kg; 24 h) (Figure 1F) caused significant
reduction in serum levels of ALT and liver injury, which
was not reproduced in vivo by selective P2Y receptor an-
tagonism (reactive blue-2; 10-100 mg/Kg; 24 h - data not
shown). All pharmacological strategies directed toFigure 1 Extracellular ATP signaling enhances APAP-induced hepatot
GFP-expressing neutrophils (in green). Mice were treated with acetaminoph
hours after APAP treatment. Control mice were wild type C57 or Lysm-eGF
liver injury were observed between C57 and C57-Lysm-eGFP expressing m
apyrase-treated mice. (B) H&E stained liver sections confirmed liver injury a
apyrase. (C) Circulating levels of liver transaminase (ALT) and (D-E) pro-infla
challenged mice treated with different purinergic receptors antagonists TN
* P < 0.05 in comparison to control group and ** in comparison to vehicle-dampen extracellular ATP signaling, including cleavage
by apyrase or different P2 receptor antagonists (TNP-
ATP and oxi-ATP), reduced liver inflammation, necrosis
(as assessed by histological score from H&E slides; Add-
itional file 4: Figure S1), and neutrophil infiltration
(Figure 1G). Acute liver injury led to remote lung in-
flammation (Figure 2A; control in comparison to APAP),
with concomitant pulmonary leukocyte accumulation
(Figure 2B). Leukocytes recovered from BAL were
predominately macrophages (Figure 2C). While dampen-
ing ATP sensing resulted in significantly less liver
damage and inflammation, no detectable effects on pul-
monary injury (Figure 2A) or lung leukocyte infiltration
(Figure 2B-C) were observed.
HepG2 cells release ATP following acetaminophen
incubation
To expand our in vivo findings, we established an
in vitro model of APAP cytotoxicity using both primary
mouse hepatocytes and a human lineage of hepatocyticoxicity. (A) Liver intravital microscopy showing sinusoids (in red) and
en (500mg/Kg; 24 h) and a group received apyrase (25 U/mice) 2
P (in intravital microscopy studies). No significant differences regarding
ice. Note the reduced liver injury and neutrophil recruitment in
nd partial protection promoted by extracellular ATP metabolism by
mmatory cytokines (TNF-α and IL-1β). (F) Serum ALT levels of APAP-
P-ATP (selective P2X, 1 mg/Kg) and oxi-ATP (selective P2X7, 9 mg/Kg).
treated group. N = 5/group. Data are mean ± SEM. Scale: 100 μm.
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(Figure 3A; 5-20mM; 24 h), which started in the 6th hour
post-incubation, reaching 50% of cytotoxicity following 24
hours (Figure 3B; assessed by MTT metabolism). Co-
incubation with the standard APAP antidote N-acetyl
cysteine significantly prevented APAP effects on HepG2
cells, confirming that the major cause of cytotoxicity in
our in vitro model was due to APAP bioactivation to toxic
metabolites (data not shown). APAP-mediated cytotoxicity
was also evaluated by an alternative cell viability test (eth-
idium bromide/acridine orange staining). Incubation with
APAP (20mM; 24 h) caused significant reduction in the
number of viable cells in comparison to controls
(Figure 3C-E). Therefore, these settings were chosen to all
subsequent in vitro experiments.
To prove that stressed/necrotic hepatocytes could be a
relevant source of extracellular ATP, we incubated
HepG2 cells with APAP and measured ATP and ADP
concentrations in the supernatant by high-performance
liquid chromatography (HPLC). Supernatant from un-
treated cells had undetectable amounts of both ATP and
ADP. However, following APAP incubation, extracellular
ATP concentration rapidly increased, while ADP was
detected in later timepoints (Figure 3F). Interestingly,
cleavage of extracellular ATP reverted APAP cytotoxicity
(Figure 3G), which was reproduced by unspecific block-
age of P2 receptors by suramin (0.01-0.1 mM; 24 h)Figure 2 APAP-induced remote lung injury was not reduced following
histology from control mice showing normal morphological findings, while
apyrase treated group (25 U/mice). Representative images from five differen
(BAL) from APAP treat mice showing that liver injury triggered remote lung
(C) Macrophages were the most frequent cell type found in BAL. * - P < 0.0
post-test. Data are mean ± s.e.m. N = 5/group. Data are mean ± SEM. Scale:(Figure 3H). Selective participation of different P2 recep-
tors subfamilies was also investigated. Specific P2X
receptors antagonism by PPADS (0.1-100 μM; 24 h) or
TNP-ATP (0.1-100 μM) also partially prevented APAP
cytotoxicity, as well as selective blockage of P2Y recep-
tors by reactive blue-2 (3-30 μM) (Figure 3H). While se-
lective P2X7 blockage (by oxi-ATP) prevented APAP
hepatotoxicity in vivo, no detectable effects were
observed in vitro using a large dose range (10-100 μM;
24 h) (Additional file 5: Figure S2). These data suggest
that not a specific subtype, but several ATP and ADP
receptors may be involved in extracellular purinergic sig-
naling during necrosis, and their combined stimulation
may enhance cell death independently of the immune
system activation.
In this context, we hypothesized that ATP might be
directly harmful in concentrations that are biologically
relevant. In fact, in the same titers found in medium
recovered from APAP-challenged cells, both ATP and
ADP were directly cytotoxic to “naïve” HepG2 cells (10
μM, Figure 3I, Additional file 4: Figure S1). ATP-
mediated toxicity was detected in early timepoints (6 h),
persisting until the end of incubation period (24 h,
Figure 3I), which was also confirmed by ethidium brom-
ide/acridine orange staining (Figure 3J; control in com-
parison to APAP). Subsequently, we examined whether
the effects observed following ATP incubation wereextracellular ATP cleavage or P2 receptors blockage. (A) Lung
APAP-treated mice presented marked lung inflammation, similarly to
t mice/group. (B) Leukocyte numbers in bronchial-alveolar lavage
inflammation, which was not prevented by dampening ATP sensing.
5 in comparison to control group, ANOVA followed by Bonferroni
100 μm.
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used a non-hydrolysable ATP (ATP-γ-S) in the same
dose range and confirmed that this stable analogue was
equally able to deflagrate cell death (Figure 3I).
Increased intracellular Ca2+ availability underlies the
mechanisms by which ATP/P2 receptors activation
contribute to APAP-mediated cell death
To investigate the biological relevance of extracellular pur-
ines during necrosis, we measured the Ca2+ signal ampli-
tude by confocal microscopy when HepG2 cells were
challenged with ATP or ADP in the same concentrationFigure 3 ATP is released and accounts to additional cell death during
challenged HepG2 cells (24 h). (C-E) Acridine orange/ethidium bromide via
in HepG2 supernatant (HPLC) in different timepoints after APAP incubation
P2Y blockers (0.1 mM, 100 μM and 30 μM, respectively) on APAP-mediated
HepG2 cells, confirmed by acridine orange/ethidium bromide viability test.
experiments. * P < 0.05 in comparison to control group and ** in comparisrange found during APAP-mediated cytotoxicity (10 μM).
Following ATP or ADP administration, marked intracellu-
lar Ca2+ signals were observed in comparison to controls,
which were sustained and repeated throughout the incuba-
tion time (Figure 4A). Strikingly, “naïve” HepG2 cells that
received supernatant collected from APAP-treated cells
(Figure 4B) also displayed enhanced intracellular Ca2+ sig-
nal, which was completely abolished by incubation with
apyrase or unspecific P2 receptor antagonist suramin
(Figure 4C). These data suggest that such extracellular con-
centrations of ATP and ADP may play an important role in
intracellular Ca2+ mobilization in during APAP incubation.APAP incubation. (A-B) Dose and time-response curves of APAP
bility test confirmed APAP cytotoxicity. (F) ATP and ADP quantification
(20 mM). (G-H) Effects of apyrase (10 U/ml) or different P2, P2X and
cell death. (I-J) Direct cytotoxic effect of ATP and ADP on “naïve”
Controls (medium alone) were not different throughout the
on to vehicle or medium treated group.
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also able to modify cell responsiveness to extracellular
ATP released during necrosis. For this, we cultured
HepG2 cells in the presence or absence of APAP
(20mM) for 24 hours (Figure 4D). Original medium was
removed and intracellular Ca2+ signal was triggered by
the same extracellular ATP concentration found during
APAP treatment (10 μM). Following ATP administration,
the remaining viable APAP-treated cells displayed
higher, sustained and repeated Ca2+ signals (Figure 4E-F,
Additional file 6: Video 4), while control cells had lower
intracellular Ca2+ increase and rapidly returned to base-
line values (Figure 4E-F, Additional file 7: Video 5).
Additionally, we observed that not only APAP-treated
cells were hyper-responsive to ATP, but the majority of
the reactive cells reached higher fluorescence values
than untreated cells, indicating a both quantitative and
qualitative change in Ca2+ dynamics during APAP incu-
bation (Figure 4G).
To confirm that unbalanced calcium signal was
involved in APAP cytotoxicity, we treated HepG2 cells
with an intracellular Ca2+ scavenger (BAPTA-AM;
1 nM) throughout APAP challenge. Incubation with
BAPTA-AM reduced APAP-mediated cell death in 50%
(Figure 4H), suggesting that increased intracellular
calcium availability contributed to APAP-mediated cell
death.
Primary mouse hepatocytes also developed hyper-
responsiveness to extracellular ATP following APAP
exposure, which is prevented by P2 receptor antagonism
To validate our data obtained in HepG2 cells, we
obtained primary hepatocytes from mice (Figure 5A)
and incubated with different APAP and ATP doses (5-40
mM and 10-100 μM, respectively). As shown in
Figure 5B, APAP incubation decreased cell viability
(18 h) in a dose dependent manner. Incubation with
APAP (20 mM) caused 50% of cell death, and this dose
was chosen for subsequent experiments. Following
exogenous ATP administration in the same dose found
during necrosis (10 μM), naïve mouse hepatocytes incu-
bated with APAP (20 mM; 6 h) increased intracellular
calcium signal, and returned to baseline values after 60
seconds (Figure 5C and 5G; Additional file 8: Video 6).
However, APAP-treated primary hepatocytes presented
prolonged (Additional file 9: Video 7) or repeated intra-
cellular calcium signal (Figure 5D and 5G; Additional file
10: Video 8), reaching higher fluorescence values in both
cases. APAP-treated primary hepatocytes remained
responsive to exogenous ATP for longer periods (~200
seconds; 3-fold increase; Figure 5D) in comparison to
controls (~70 seconds, Figure 5C). ATP-triggered
calcium increase was totally abrogated when APAP-
challenged cells were treated with a P2R blocker(suramin; Figure 5E; Additional file 11: Video 9), sug-
gesting that, analogous to HepG2 cells, APAP incubation
also caused hyper-responsiveness to extracellular ATP in
primary mouse hepatocytes. Moreover, incubation of pri-
mary hepatocytes with exogenous ATP in the dose range
found during necrosis (10-100 μm, 18 h) significantly
reduced cell viability, confirming that in biological
relevant concentrations extracellular ATP may be also
directly cytotoxic to mouse liver cells (Figure 5H).
Increased expression of several purinergic receptors may
explain the hyper-responsiveness to ATP during necrosis
In order to elucidate the mechanisms involved in the
increased sensitivity to extracellular purines displayed by
APAP-treated cells, we measured the expression of several
purinergic receptors. Quantitative PCR analysis revealed
that numerous P2 receptors (P2X1, P2X2, P2X7, P2Y2,
P2Y4) and ectonucleotidases (NTPDase 1 and 6) were
upregulated during APAP incubation in comparison to
controls (Figure 6A), which could be one of the reasons for
the elevated Ca2+ signal triggered by ATP in APAP-
incubated cells. Taking into account the detrimental effects
of an exacerbated extracellular ATP signaling during necro-
sis, we hypothesized that the elevated expression of
NTPDases might consist in a mechanism for ATP signaling
restriction and cell protection, driving extracellular ATP
metabolism ultimately to adenosine. In fact, in vitro incuba-
tion with adenosine was not only innocuous to HepG2 cells
(Figure 6B), but also partially reverted APAP-mediated
cytotoxicity (Figure 6C). Corroborating this protective loop,
an increased expression of adenosine A2a receptor (A2aR)
was observed in APAP-challenged cells. In fact, A2aR is
described to reduce inflammatory reactions and accelerate
healing when binding to adenosine [18]. Such protective
profile was also confirmed in vivo, since blockage of adeno-
sine receptors with an unspecific P1 antagonist (theophyl-
line) worsened APAP-mediated liver injury (Figure 6D).
To validate our findings in humans, we investigated
the profile of purinergic receptors expression in patients
diagnosed with drug-induced acute hepatitis. In agree-
ment, several P2 receptors were also upregulated in
acute hepatitis patients in comparison to healthy donors
(Figure 6E), suggesting that altered cell responsiveness
to extracellular purines may be also relevant in the con-
text of liver injury progression. In addition, enhanced
purinergic receptor expression (P2X2, P2X7 and P2X1;
Figure 6F) was correlated with higher grades of liver
injury (assessed by serum ALT levels) in several acute
hepatitis patients (Pearson’s correlation; r).
Discussion
Extracellular ATP is a well-characterized damage-associated
molecular pattern (DAMP), which activates the NLRP3
inflammasome via P2X7 receptors, inducing production
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[5,11,19,20]. The majority of in vitro studies com-
monly use elevated concentrations of ATP (ranging
from 1 to 10 mM) and short incubation regimes to
induce cell activation, particularly leukocytes [21-23].
However, these conditions are unlikely to represent
any in vivo environment found under either physio-
logical or pathological circumstances [24]. For in-
stance, extracellular ATP concentration increases
during inflammatory responses, but it reaches max-
imum concentrations in the range of hundred micro-
molars [25]. So far, the damage exerted by increased
extracellular concentrations of ATP has been solely
attributed to indirect, inflammatory effects over im-
mune cells [11,26]. In this study, we showed that
ATP and ADP have direct cytotoxic effects in hep-
atic cells and may have profound influence in theFigure 4 Hyper-responsiveness to ATP increased intracellular Ca2+ sig
(10 μM) in HepG2 cells. (B-C) Culture medium from necrotic/suffering cells
abolished by apyrase (10 U/ml) or P2 blocker suramin (0.1 mM). (D-E) Snaps
treated or not with APAP at 20 mM. (F-G) ATP-triggered Ca2+ signals from
by BAPTA-AM (1 nM) partially reverted APAP-mediated cell death. * P < 0.05
medium treated group.pathogenesis of acute liver failure. We provided evi-
dence that ATP signaling during necrosis might have
a double-faceted action by i) enhancing inflammatory
response via IL-1β release and ii) directly causing hepato-
toxicity due to a hyper-responsiveness behavior to ATP and
increased intracellular Ca2+ availability.
In this study, we used a murine model of APAP poi-
soning to show that activation of several P2 receptors is
detrimental during liver injury progression. Confocal
intravital microscopy revealed remarkable changes in the
liver environment during APAP overdose that were
dependent on extracellular ATP signaling. Also, harmful
effects of P2 receptor agonists seems to be restricted to
the liver, since blockage of ATP/ADP sensing was not
effective in preventing remote lung injury. In fact, des-
pite the hepatoprotection and the reduced levels of
circulating cytokines promoted by apyrase treatment,nal during APAP challenge. (A) Ca2+ signal induced by ATP and ADP
triggered intracellular Ca2+ signal in “naïve” HepG2 cells, which was
hots from confocal microscopy showing Ca2+ signal in HepG2 cells
cells incubated or not with APAP for 24 hours. (H) Ca2+ sequestration
in comparison to control group and ** in comparison to vehicle or
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cient to support lung inflammation [17]. In line with this
interpretation, recent work demonstrated that increased
serum levels of ATP found during hepatectomy were
only transient (~ 5 minutes) and rapidly returned to
baseline values [27]. These data indicate that while
extracellular ATP and ADP play a key role in local liver
injury, they are not mediators of remote inflammatory
responses.
Also, we performed a series of in vitro experiments to
determine if hepatocytes could constitute a relevant
source of extracellular ATP. Subsequently to APAP incu-
bation, higher concentrations of ATP and ADP were
found in the culture medium recovered from stressed/
necrotic HepG2 cells in comparison to controls. Taking
into account that these titers were sufficient to directly
induce HepG2 death, we postulated that ATP releasedFigure 5 APAP-challenged primary hepatocytes presented sustained
administration. (A) Primary mouse hepatocytes (PMH) were isolated and l
APAP incubation (18 h), PMH viability decreased in a dose-dependent man
Therefore, this dose was used to subsequent experiments. (C) ATP adminis
returned to baseline values after 60 seconds. Six replicates are represented
a hyper-responsive behavior to the same ATP dose, displaying higher and
(200 seconds). (E) Treatment with an unspecific P2 antagonist (suramin, 0.1
(F) Representative cells of each group were displayed together. (G) Snapsh
Videos were rendered in “rainbow pallet” to facilitate fluorescence observat
stimulation, APAP treated cells remaining responsive with increased intrace
after 55–70 seconds. Scale = 20 μm. (H) Incubation of primary hepatocytes
(10-100 μm, 18 h) significantly reduced cell viability. * P < 0.05 in comparisofrom a suffering or necrotic cell binds to P2 receptors in
a challenged, neighboring cell and increases its intracel-
lular Ca2+ concentration in sufficiently high levels to ac-
celerate cell damage or even death. It is possible that
off-target factors, including alterations in probe hydroly-
sis or intracellular pH variations could contribute to
Fluo-4AM fluorescence variations observed in the
current study. However, these factors possibly had a
minor impact in our results, as we were able to signifi-
cantly abrogate ATP-mediated increase in intracellular
calcium signal with P2R antagonist treatment. Therefore,
our data suggest that the main pathway involved in
altered cell responsiveness in our model is related to
P2R signaling. In fact, paracrine communication between
hepatocytes mediated by ATP was previously reported
[28], and blockage of cell-cell interaction via gap junc-
tions may hold opportunities to restrict liver damageand repeated intracellular calcium signal due to exogenous ATP
oaded with a fluorescent calcium probe (Fluo4-AM). (B) Following
ner, reaching 50% of survival when 20 mM of APAP was used.
tration (10 μM) caused calcium signal in naïve hepatocytes, which
in the graph. (D) However, APAP-treated cells (20 mM; 6 h) developed
sustained calcium signal, which was also prolonged for longer periods
mM) completely abrogated APAP effects over ATP stimulation.
ots from live calcium signal recording using confocal microscopy.
ion (generated by Fluo4-AM). Following 110 seconds of ATP
llular calcium signal, while control cells returned to baseline values
with exogenous ATP in the dose range found during necrosis
n to control group. Data are mean ± SEM.
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confirmed that extracellular ATP may enhance APAP-
mediated liver damage in vivo via activation of P2X7 and
P2Y2 [30,31]. Thus, we suggest that necrotic/suffering
hepatocytes may efficiently supply extracellular ATP to
fuel both immune system activation and direct hepato-
toxicity. Likewise, in vitro effects were not restricted to
single receptor activation (e.g. P2X7), but rather
mediated by different P2 receptors subfamilies, suggest-
ing that larger spectrum inhibition might be necessary
to promote appreciable cytoprotection.Figure 6 Up-regulation of several purinergic receptors may explain h
PCR for purinergic receptors from cells cultivated in the presence or absen
baseline expression. (B-C) HepG2 incubation with adenosine in the presenc
treated with theophylline (P1 receptor blocker, 20 mg/Kg). (E) Quantitative
comparison to healthy volunteers. Baseline expression was determined by
different P2 receptors were compared to serum ALT levels from healthy an
correlated with higher serum ALT levels in several patients. Pearson’s corre
serum ALT levels (r). * P < 0.05 in comparison to control group and ** in coATP induces intracellular signals by mobilizing Ca2+
from cytosolic and nuclear stocks [14] or allowing its in-
flux across the membrane [32]. Interestingly, in situa-
tions of deprivation of mitochondrial ATP, as seen
throughout APAP challenge, cells may upregulate P2
receptors to increase intracellular Ca2+ and stimulate
ATP synthesis within mitochondria as a tentative to es-
cape from an irreversible damage [7-9]. Accordingly,
both primary mouse hepatocytes and HepG2 cells devel-
oped a hyper-responsive behavior to exogenous ATP fol-
lowing APAP administration, which may be correlatedyper-responsiveness to ATP during hepatotoxicity. (A) Quantitative
ce of APAP (20 nM; 24 h). Untreated HepG2 cells (C) determined
e or absence of APAP. (D) Serum ALT levels of APAP-challenged mice
PCR analysis of liver samples from acute hepatitis patients in
choosing a healthy volunteer as control. (F) Changes in expression of
d acute hepatitis patients. Note that increased P2R expression was
lation was calculated comparing fold increase of P2R expression to
mparison to vehicle treated group.
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tors. Therefore, we propose that such change in P2R levels
observed in both APAP-treated cells and in liver biopsies
from acute hepatitis patients may be a strategy to restrict
cell suffering through P2 receptors-mediated intracellular
Ca2+ increase. However, APAP challenge may disturb im-
portant intracellular mechanisms that manage Ca2+
compartmentalization, since challenged cells displayed ele-
vated intracellular Ca2+ signal in our in vitro model. In this
context, cytoprotection promoted by intracellular calcium
sequestration (using BAPTA-AM) provided interesting
insights for future investigations focused on elucidate the
most important calcium sources that extracellular ATP
recruits to boost APAP-triggered hepatotoxicity. It is worth
taking into consideration that although we observed P2 re-
ceptor upregulation in HepG2 cells following APAP chal-
lenge, it is conceivable that purinergic signaling in other
cell types (i.e. liver resident cells and infiltrating leukocytes)
is also involved in the development of acute liver failure
caused by APAP administration. Furthermore, although we
confirmed APAP cytotoxicity by two different methodolo-
gies, alterations in cell metabolic pathways following APAP
overdose (i.e. mitochondrial activity and cell proliferation
rate) may also contribute to the mechanisms involved in
APAP cytotoxicity.
Conclusions
We provided novel evidence that within the liver envir-
onment ATP acts not only as an immune system activa-
tor, but also as a direct cytotoxic DAMP by increasing
intracellular Ca2+ concentration. Also, while upregula-
tion of P2 receptors may consist in a physiological strat-
egy to regulate cell functions, the hyper-responsiveness
behavior to biologically relevant concentrations of ATP
accounted to additional hepatotoxicity (Figure 7). These
findings have clear implications for liver disease patho-
genesis and therapy, providing rationale to alternative




C57BL/6 mice were from Centro de Bioterismo in
UFMG (Brazil). Lysm-eGFP mice were donated by Dr.
Paul Kubes (University of Calgary, Canada). All proce-
dures were approved by Animal Care and Use Commit-
tee in UFMG (CEBIO n°051/2011). The investigation
conformed to the standards of Guide for the Care and
Use of Laboratory Animals (National Institutes of Health
publication 85–23, 1996 revision).
Model of APAP-induced liver injury
Mice were fasted for 15 hours before oral APAP admin-
istration (500 mg/kg; Sigma, USA) or vehicle (warmsterile saline). After different time-points, mice were
anesthetized and euthanized for blood (serum), liver,
BAL (bronchial-alveolar lavage) and lung harvesting.
ALT determination was performed using a kinetic test
(Bioclin, Brazil) and cytokines and chemokines were
quantified by ELISA kits (R&D systems, USA) both in
serum and tissues. Fragments of liver and lung were
fixed in formalin and sectioned for histology (H&E).
Histological score was assessed by an experienced path-
ologist, in which 0: no lesion present; 1/2: individual
necrotic cells seen at the first cell layer adjacent to the
central vein, and hyaline degeneration present; 1: nec-
rotic cells extending two or three cell layers from the
central veins; 2: necrotic cells extending three to six cell
layers from the central veins, but limited in peripheral
distribution; 3: the same as 2, but with necrosis extend-
ing from one central vein to another; 4: more severe
than 3, with extensive centrilobular necrosis throughout
the section. A final score was given for each liver section
[33]. Serum mitDNA (cytochrome C primer) was esti-
mated by Real-Time PCR as previously described [34].
Neutrophil infiltration into the liver was estimated by
the myeloperoxidase activity assay (MPO) [35]. In a
separated set of experiments, the liver was imaged using
confocal intravital microscopy as described previously
[16]. Three-dimensional video reconstructions were
made using confocal Z-stacks (40 μm; 1 μm step) and
mounted using Volocity software (Perkin-Elmer, USA).
BAL was collected for leukocyte counting [36]. All ex-
perimental groups included N ≥ 5.
In vivo drugs and treatments
Mice received APAP (500 mg/Kg; Sigma) by oral gavage
diluted in warm saline. This dose of APAP is almost
completely metabolized within 1.5-2 hours [37]. There-
fore, all pharmacological treatments were performed two
hours after APAP gavage to avoid interference in APAP
bioactivation and off-target effects. Suramin (5 mg/Kg;
i.v.), TNP-ATP (1 mg/Kg; i.v.), oxidized-ATP (oxi-ATP;
9 mg/Kg; i.v.), reactive blue-2 (10-100 mg/Kg; i.p.), apyr-
ase (25 U/mice; i.v.) and theophylline (20 mg/Kg) were
dissolved in sterile saline following supplier instructions
(Sigma, USA).
In vitro HepG2 assays
HepG2 (American Type Culture Collection) cells were
maintained at 37°C under an atmosphere of 5% CO2 in
complete RPMI1640 medium containing 10% FBS and
cultured in 105 cells/well in 96 wells plates. After 24
hours of incubation the supernatant was replaced by
medium without FBS containing the treatments [38].
APAP (5-20 mM), suramin (0.01-0.1 mM), TNP-ATP (0.1-
100 μM), PPADS (0.1-100 μM), oxi-ATP (10-1000 μM),
apyrase grade IV (10 U/mL), reactive blue-2 (3-30 μM, a
Figure 7 Proposed mechanism: 1: Under physiological conditions, extracellular ATP regulates several intracellular signaling pathways,
which involves also calcium compartmentalization. 2–3: Acetaminophen incubation directly causes hepatocyte necrosis, calcium imbalance
and further ATP release. 4: In parallel, challenged viable hepatocytes up-regulate several purinergic receptors, probably as a regulatory
homeostatic strategy, causing ATP hyper-responsiveness. Binding of extracellular ATP to purinergic receptors increases intracellular Ca2+ and
pulses, which accounted to additional cell necrosis, reverberating APAP-induced death. Dampening of extracellular ATP signalling or reducing
intracellular Ca2+ availability significantly reduced hepatocyte necrosis. Data from FHF patients suggest that a similar necrosis-amplification
pathway may be involved in organ injury progression.
Table 1 Clinical data of patients enrolled in the study
Patient ID Age ALT (U/L) INR serum bilirubin (mg/dl)
Acute Hepatitis
(n = 15)
6-55 122-7300 3.3-18.2 3.5-37
Healthy donors
(n = 5)
25-38 <40 ND ND
Serum levels of liver transaminase (ALT) and bilirubin from patients enrolled in
the study. Liver biopsies were collected during transplantation procedures.
INR: International Normalized Ratio, ND: non-determined.
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University, Japan), ATP (1-100 μM), ATP-γ-S (10 μM),
ADP (1-10 μM), adenosine (0.1-10 μM) and BAPTA-AM
(1 nM) were dissolved in DMSO or water following sup-
plier instructions (Sigma, USA), and added into culture
medium to incubation throughout the experiments. Work-
ing doses were chosen based on dose-response curves pre-
viously established in our group (Additional file 5: Figure
S2). Cell viability was assessed by MTT metabolism assay
(Sigma, USA) or by ethidium bromide/acridine orange via-
bility assay [39]. Purinergic receptors and ectonucleoti-
dases expression was quantified by Real-Time PCR as
described previously [40,41]. Experiments were repeated at
least three times, using 12 replicates per group.Primary mouse hepatocytes (PMH) isolation and culture
PMH were isolated as previously described [42,43].
Briefly, the portal vein was cannulated, and a solution
collagenase B (4 mg/ml; Roche; from C. histolyticum)
was perfused during 8 minutes (5 ml/min). Following
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and stomach, and carefully minced in a plastic Petri dish
in Williams’s medium and the resultant cells were
double filtered in serial nylon mesh filters. The cell sus-
pension was washed twice with William’s medium and
ressuspended in William’s medium containing 50 U of
penicillin and 50 mg of streptomycin. This protocol
yielded a high rate of viable hepatocytes (>95% as
assessed by commercial fast hematological staining kit
and Trypan blue exclusion). Cells were then seeded on
collagen I-treated glass coverslips (3 × 105 cells/well)
and cultured using 6-wells plates to further MTT and
calcium signal assays (as described previously for HepG2
cells).
Analysis of extracellular nucleotides by HPLC
Cells were incubated in presence or absence of APAP
and supernant was recovered in different timepoints.
Aliquots of 40 μL were applied to a reverse phase HPLC
system using a C18 Shimadzu column (Shimadzu, Japan)
with absorbance measured at 260 nm. The mobile phase
was 60 mM KH2PO4, 5 mM tetrabutylammonium chloride,
pH 5.9, in 15% methanol. Retention times were assessed
using standard samples of ATP and its metabolites.
Detection of intracellular Ca2+ signals with confocal
microscopy
Nuclear and cytosolic Ca2+ were monitored in individual
cells by using time-lapse confocal microscopy, as described
[14]. Cells were incubated with 4 μM cell permeant
fluo-4-AM (fluo-4 acetoxymethyl ester; Molecular Probes)
and all fluorescence analyses were performed offline using
ImageJ software (NIH) as previously described [14].
Human patients
Fifteen patients diagnosed with non-viral and suspected
of drug-induced acute liver failure addressed to the Liver
Clinic of Hospital Federal de Bonsucesso of Rio de
Janeiro were enrolled for this study (Table 1). Inclusion
criteria demanded the development of coagulopathy
(prothrombin time activity > 15 s) or international nor-
malized ratio (INR) ≥ 1.5, and hepatic encephalopathy
within 8 weeks of jaundice onset in the absence of
pre-existing liver disease. Liver samples were also
collected from 5 healthy subjects (liver donors) for the
experiments. Expression of purinergic receptors and ecto-
nucleotidases were quantified by Real-Time PCR as
described previously [40,41]. Liver samples were collected
and immediately frozen in liquid nitrogen and kept in –80°C
until processing for PCR analysis. This study was approved
by Institutional Review Boards (CEP-Fiocruz 22/03) and per-
formed under an informed consent by all participants. The
study protocol conformed to the ethical guidelines of the
1975 Declaration of Helsinki.Statistics
Statistical analyses were performed using one-way
ANOVA (Dunnett or Bonferroni post-test) or Student’s t
test. P values less than 0.05 were considered statistically
significant. Pearson’s correlation was calculated by Excel
2011 for Mac (Microsoft). All data are presented as
mean ± SEM.Additional files
Additional file 1: Video 1. Three-dimensional Z-stack rendering from
liver confocal intravital microscopy – Control mouse. Lysm-eGFP mice
were used to visualize neutrophil infiltration and sinusoidal perfusion.
Sinusoids were stained by i.v. injection of PE-coupled anti-PECAM-1. Z-
stacks were made (depth: 40 μm) and TIFF-acquired images were
mounted by using Volocity software (NIH, USA). Mice were imaged by
sequential laser scans (2.71 seconds).
Additional file 2: Video 2. Three-dimensional Z-stack rendering from
liver confocal intravital microscopy – Acetaminophen-treated mouse.
Lysm-eGFP mice were treated with acetaminophen (APAP; 500 mg/Kg;
24 h) and prepared to visualization of neutrophil infiltration and liver
sinusoidal perfusion. Sinusoids were stained by i.v. injection of PE-
coupled anti-PECAM-1. Z-stacks were made (depth: 40 μm) and TIFF-
acquired images were mounted by using Volocity software (NIH, USA).
Mice were imaged by sequential laser scans (2.71 seconds).
Additional file 3: Video 3. Three-dimensional Z-stack rendering from
liver confocal intravital microscopy – Apyrase treated acetaminophen-
challenged mouse. Lysm-eGFP mice were treated with acetaminophen
(APAP; 500 mg/Kg; 24 h) and apyrase (25 U/mice, 2 hours after APAP) and
prepared to visualization of neutrophil infiltration and liver sinusoidal
perfusion. Sinusoids were stained by i.v. injection of PE-coupled anti-
PECAM-1. Z-stacks were made (depth: 40 μm) and TIFF-acquired images
were mounted by using Volocity software (NIH, USA). Mice were imaged
by sequential laser scans (2.71 seconds).
Additional file 4: Figure S1. H&E slides and histological score from
mice treated with different P2R antagonists and challenged with APAP.
Mice were treated (2 hours after APAP challenge; 500 mg/Kg; 24 h) with
apyrase (25 U/mice), TNP-ATP (1 mg/Kg; i.v.), oxidized-ATP (oxi-ATP; 9 mg/
Kg; i.v.) or reactive blue-2 (10-100 mg/Kg; i.p.). Histological score was
assessed using 0: no lesion present; 1/2: individual necrotic cells seen at
the first cell layer adjacent to the central vein, and hyaline degeneration
present; 1: necrotic cells extending two or three cell layers from the
central veins; 2: necrotic cells extending three to six cell layers from the
central veins, but limited in peripheral distribution; 3: the same as 2, but
with necrosis extending from one central vein to another; 4: more severe
than 3, with extensive centrilobular necrosis throughout the section. A
final score was given for each liver section. * - P < 0.05 in comparison to
control (C) group and ** in comparison to vehicle treated group. Data
are mean ± SEM. Scale: 100 μm.
Additional file 5: Figure S2. Dose–response curves of ATP, ADP and
different purinergic receptors antagonists. (A) Dose–response curve ATP
and (B) ADP incubation upon HepG2 cells. (C-D) Dose–response curves of
suramin (non-selective P2 antagonist; alone and with APAP),
(E-F) TNP-ATP (P2X blocker; alone and with APAP), (G-H) PPADS (P2X
blocker; alone and with APAP), (I-J) oxi-ATP (specific P2X7 blocker; alone
and with APAP) or (K-L) reactive blue-2 (P2Y blocker; alone and with
APAP). * - P < 0.05 in comparison to control (C) group and ** in
comparison to medium treated group.
Additional file 6: Video 4. Detection of intracellular Ca2+ signals with
confocal microscopy - APAP treated HepG2 cells. Nuclear and cytosolic
Ca2+ were monitored in individual cells by using time-lapse confocal
microscopy. HepG2 cells were cultured on glass coverslips in a density of
3×105 cells/well in 6 wells plates and kept in a Hepes-buffered solution
during experiments. Cells were incubated with APAP (10 mM) and after
24 hours 4 μM cell permeant Fluo4-AM (fluo-4 acetoxymethyl ester;
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trigger intracellular calcium signal.
Additional file 7: Video 5. Detection of intracellular Ca2+ signals with
confocal microscopy - Control HepG2 cells. Nuclear and cytosolic Ca2+
were monitored in individual cells by using time-lapse confocal
microscopy. HepG2 cells were cultured on glass coverslips in a density of
3×105 cells/well in 6 wells plates and kept in a Hepes-buffered solution
during experiments. Cells were incubated with 4 μM cell permeant Fluo4-
AM (fluo-4 acetoxymethyl ester; Molecular Probes) was added to the
culture. ATP (10 μm) was used to trigger intracellular calcium signal.
Additional file 8: Video 6. Detection of intracellular Ca2+ signals with
confocal microscopy – Control primary hepatocytes. Nuclear and
cytosolic Ca2+ were monitored in individual cells by using time-lapse
confocal microscopy. Primary mouse hepatocytes were cultured on glass
coverslips in a density of 3×105 cells/well in 6 wells plates and kept in a
Hepes-buffered solution during experiments. Cells were incubated with
APAP (20 mM) and after 6 hours 4 μM cell permeant Fluo4-AM (fluo-4
acetoxymethyl ester; Molecular Probes) was added to the culture. ATP
(10 μm) was used to trigger intracellular calcium signal.
Additional file 9: Video 7. Detection of intracellular Ca2+ signals with
confocal microscopy – APAP-treated primary hepatocytes displayed
sustained calcium signal following ATP administration. Nuclear and
cytosolic Ca2+ were monitored in individual cells by using time-lapse
confocal microscopy. Primary mouse hepatocytes were cultured on glass
coverslips in a density of 3×105 cells/well in 6 wells plates and kept in a
Hepes-buffered solution during experiments. Cells were incubated with
APAP (20 mM) and after 6 hours 4 μM cell permeant Fluo4-AM (fluo-4
acetoxymethyl ester; Molecular Probes) was added to the culture. ATP
(10 μm) was used to trigger intracellular calcium signal.
Additional file 10: Video 8. Detection of intracellular Ca2+ signals with
confocal microscopy – APAP-treated primary hepatocytes displayed
repeated calcium signal following ATP administration. Nuclear and
cytosolic Ca2+ were monitored in individual cells by using time-lapse
confocal microscopy. Primary mouse hepatocytes were cultured on glass
coverslips in a density of 3×105 cells/well in 6 wells plates and kept in a
Hepes-buffered solution during experiments. Cells were incubated with
APAP (20 mM) and after 6 hours 4 μM cell permeant Fluo4-AM (fluo-4
acetoxymethyl ester; Molecular Probes) was added to the culture. ATP
(10 μm) was used to trigger intracellular calcium signal.
Additional file 11: Video 9. Detection of intracellular Ca2+ signals with
confocal microscopy – responsiveness to exogenous ATP. Nuclear and
cytosolic Ca2+ were monitored in individual cells by using time-lapse
confocal microscopy. Primary mouse hepatocytes were cultured on glass
coverslips in a density of 3×105 cells/well in 6 wells plates and kept in a
Hepes-buffered solution during experiments. Cells were incubated with
APAP (20 mM) and suramin (0.1 mM) and after 6 hours 4 μM cell
permeant Fluo4-AM (fluo-4 acetoxymethyl ester; Molecular Probes) was
added to the culture. ATP (10 μm) was used to trigger intracellular
calcium signal.
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